Every S-3 that Healthcare Triangle Inc (HCTI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-3 covers the shelf registration that lets an established company sell over time, so if you follow HCTI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HCTI filings page.
Healthcare Triangle, Inc. registers 28,000,000 shares of Common Stock for resale by Hudson Global Ventures, LLC. The resale registration covers up to 27,950,000 ELOC Shares and 50,000 Exercise Shares underlying a warrant issued in connection with an Equity Line of Credit Purchase Agreement (the ELOC Purchase Agreement). The Company will not receive proceeds from shares resold by the Selling Stockholder; however, the Company may receive up to $50,000,000 in aggregate gross proceeds if it elects to sell shares to the Selling Stockholder under the ELOC Purchase Agreement, which is subject to customary conditions and a 4.99% beneficial ownership limitation. The Company’s Common Stock is listed on the Nasdaq Capital Market under the symbol HCTI.
Healthcare Triangle, Inc. (HCTI) has filed a pre-effective amendment to register 1,458,118 shares of common stock for resale by existing security holders. These shares consist of 1,429,528 shares issuable upon exercise of inducement warrants and 28,590 shares issuable upon exercise of advisor warrants granted in connection with an October 2025 warrant inducement transaction. The company is not selling shares itself under this prospectus and will not receive proceeds from any resale, though it has already received $2.85 million from the prior warrant exercise and may receive additional cash if the new warrants are exercised at their $3.00 exercise price. If all common warrants are exercised, common stock outstanding would be 5,873,303 shares. The filing also highlights HCTI’s cloud, data, and AI-driven healthcare IT platforms and notes that adding freely tradable shares could pressure the stock price and dilute existing holders.
Healthcare Triangle, Inc. filed an S-3 registering the resale of up to 1,458,118 shares of common stock issuable upon exercise of previously issued warrants, including 1,429,528 shares tied to new Inducement Warrants and 28,590 shares tied to Inducement Advisor Warrants. The company is not selling shares in this registration and will receive no proceeds from any resale; it may receive cash only if warrants are exercised.
The Inducement Warrants carry a $3.00 per-share exercise price and become exercisable after stockholder approval for issuances above 19.99% of outstanding common stock, with a five-year term and a 4.99% (or 9.99% at holder election) beneficial ownership cap. The filing allows selling stockholders to use customary methods to dispose of shares. Examples of registered amounts per holder include Robert Forster 286,862 and Bigger Capital Fund, LP 191,241. The company states warrant exercise proceeds, if any, would be used for working capital and general corporate purposes.